ENDOMETRIAL CARCINOMA

Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CARCINOMA trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 3 Completed 1 Terminated 1

Promising combo trial for Hard-to-Treat uterine cancer halted early

Disease control Terminated

This study tested a combination of two drugs, futibatinib and pembrolizumab, in people with advanced endometrial cancer that had spread and was not responding to standard treatments. The goal was to see if the combination could shrink tumors or slow the disease. The trial was sto…

Matched conditions: ENDOMETRIAL CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 28, 2026 13:01 UTC

ENDOMETRIAL CARCINOMA

Get alerted when new ENDOMETRIAL CARCINOMA trials appear

Promising combo trial for Hard-to-Treat uterine cancer halted early